ADIPOQ and Stroke: Adiponectin, a major adipokine with anti-inflammatory and anti-atherogenic functions [31,32], was significantly lower in patients with atherothrombotic stroke and positively correlated with MUFA and PUFA intake, reinforcing the available evidence regarding the effects of this adipokine [59,60].